Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metronomic chemotherapy from rationale to clinical studies: A dream or reality?
Antonio Gnoni, Nicola Silvestris, Antonella Licchetta, et al.
Critical Reviews in Oncology/Hematology (2015) Vol. 95, Iss. 1, pp. 46-61
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Application of Evolutionary Principles to Cancer Therapy
Pedro M. Enríquez‐Navas, Jonathan W. Wojtkowiak, Robert A. Gatenby
Cancer Research (2015) Vol. 75, Iss. 22, pp. 4675-4680
Open Access | Times Cited: 158
Metronomic chemotherapy and immunotherapy in cancer treatment
Yu‐Li Chen, Ming-Cheng Chang, Wen‐Fang Cheng
Cancer Letters (2017) Vol. 400, pp. 282-292
Closed Access | Times Cited: 140
The Evolution and Ecology of Resistance in Cancer Therapy
Robert A. Gatenby, Joel S. Brown
Cold Spring Harbor Perspectives in Medicine (2017) Vol. 8, Iss. 3, pp. a033415-a033415
Open Access | Times Cited: 128
Glioblastoma Treatment Modalities besides Surgery
Hao Zhang, Ruizhe Wang, Yuanqiang Yu, et al.
Journal of Cancer (2019) Vol. 10, Iss. 20, pp. 4793-4806
Open Access | Times Cited: 115
<p>Management of recurrent nasopharyngeal carcinoma: current perspectives</p>
Francesco Perri, Giuseppina Della Vittoria Scarpati, Francesco Caponigro, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 1583-1591
Open Access | Times Cited: 79
Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Jingjing Miao, Lin Wang, Sze Huey Tan, et al.
JAMA Oncology (2022) Vol. 8, Iss. 12, pp. 1776-1776
Open Access | Times Cited: 38
Combinatorial immunotherapy strategies for hepatocellular carcinoma
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, et al.
Current Opinion in Immunology (2016) Vol. 39, pp. 103-113
Closed Access | Times Cited: 57
Immunotherapeutic approaches for hepatocellular carcinoma
Vito Longo, Antonio Gnoni, Andrea Casadei‐Gardini, et al.
Oncotarget (2017) Vol. 8, Iss. 20, pp. 33897-33910
Open Access | Times Cited: 55
Metronomic Oral Vinorelbine in Advanced Breast Cancer and Non-Small-Cell Lung Cancer: Current Status and Future Development
Marina Elena Cazzaniga, Andrea Camerini, Raffaele Addeo, et al.
Future Oncology (2015) Vol. 12, Iss. 3, pp. 373-387
Closed Access | Times Cited: 51
The Evolution and Ecology of Resistance in Cancer Therapy
Robert A. Gatenby, Joel S. Brown
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 10, Iss. 11, pp. a040972-a040972
Open Access | Times Cited: 41
The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis
Xingfa Huo, Jinming Li, Fuxing Zhao, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 35
Palliative systemic therapy for recurrent or metastatic nasopharyngeal carcinoma – How far have we achieved?
Victor Lee, Dora L.�W. Kwong, To‐Wai Leung, et al.
Critical Reviews in Oncology/Hematology (2017) Vol. 114, pp. 13-23
Closed Access | Times Cited: 44
The Promise of Preventive Cancer Vaccines
Pier‐Luigi Lollini, Federica Cavallo, Patrizia Nanni, et al.
Vaccines (2015) Vol. 3, Iss. 2, pp. 467-489
Open Access | Times Cited: 41
Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy
Joseph Ciccolini, Dominique Barbolosi, Christophe Meille, et al.
Cancer Research (2017) Vol. 77, Iss. 17, pp. 4723-4733
Open Access | Times Cited: 41
Tumor endothelial cells as a potential target of metronomic chemotherapy
Ji Yoon Kim, Young‐Myeong Kim
Archives of Pharmacal Research (2019) Vol. 42, Iss. 1, pp. 1-13
Closed Access | Times Cited: 41
Precision Meets Repurposing: Innovative Approaches in Human Papillomavirus and Epstein-Barr Virus-Driven Cancer Therapy
Queenie Fernandes
Cancer Letters (2024) Vol. 607, pp. 217318-217318
Closed Access | Times Cited: 4
Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice
Laura Ferrer‐Font, Lucía Villamañán, Nuria Arias‐Ramos, et al.
Pharmaceuticals (2017) Vol. 10, Iss. 1, pp. 24-24
Open Access | Times Cited: 38
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study
Andrea Casadei‐Gardini, Flavia Foca, Mario Scartozzi, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 35
Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules
Marta Banchi, Maria Christina Cox, Guido Bocci
Cancer Letters (2024) Vol. 591, pp. 216900-216900
Open Access | Times Cited: 3
Metronomic chemotherapy: bridging theory to clinical application in canine and feline oncology
Gonçalo N. Petrucci, Tomás Rodrigues Magalhães, Márcia Dias, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 3
Current achievements and future perspectives of metronomic chemotherapy
Adriana Romiti, Rosa Falcone, Michela Roberto, et al.
Investigational New Drugs (2016) Vol. 35, Iss. 3, pp. 359-374
Closed Access | Times Cited: 30
Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma
Shu‐Wei Chou, Hsiu‐Hao Chang
Cancer Letters (2024) Vol. 588, pp. 216617-216617
Closed Access | Times Cited: 3
Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide
Laura Ferrer‐Font, Nuria Arias‐Ramos, Silvia Lope‐Piedrafita, et al.
NMR in Biomedicine (2017) Vol. 30, Iss. 9
Closed Access | Times Cited: 26
Anti-angiogenic and anti-tumor effects of metronomic use of novel liposomal zoledronic acid depletes tumor-associated macrophages in triple negative breast cancer
Xinjun Cai, Zeng Wang, Jiawei Cao, et al.
Oncotarget (2017) Vol. 8, Iss. 48, pp. 84248-84257
Open Access | Times Cited: 22
Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting
Annacarmen Petrizzo, Angela Mauriello, Antonio Luciano, et al.
Oncotarget (2017) Vol. 9, Iss. 3, pp. 3576-3589
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top